Prostamax dosage chart
20 mg Vial
Prostamax is dosed at 500 mcg–1 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL. This information is for research and educational use only.
- Reconstitute
- Add 2.0 mL bacteriostatic water → 10 mg/mL concentration.
- Typical daily range
- 500 mcg–1 mg once daily (gradual titration).
- Easy measuring
- At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg (0.1 mg) on a U‑100 insulin syringe.
- Storage
- Lyophilized: refrigerate at 4 °C (39.2 °F) short‑term or freeze at −20 °C (−4 °F) long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2 weeks.
Route:
| Phase / Week | Daily Dose (mcg / mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 500 mcg (0.5 mg) | 5 units (0.05 mL) |
| Weeks 3–4 | 750 mcg (0.75 mg) | 7.5 units (0.075 mL) |
| Weeks 5–8 | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
| Weeks 9–12 (optional extension) | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
Reconstitution steps
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe.
- 2Inject slowly down the vial wall; avoid foaming.
- 3Gently swirl/roll until dissolved (do not shake).
- 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2 weeks.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes or appropriate IM syringes; dispose in a sharps container.
- Rotate injection sites among large muscle groups (deltoid, vastus lateralis, gluteus) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- For volumes ≤10 units, use 30‑ or 50‑unit syringes for better precision.
- Document daily dose and site rotation to maintain consistency.
How This Works
Prostamax (KEDP) belongs to the class of short bioregulatory peptides studied by Khavinson and colleagues. These tetrapeptides are proposed to modulate gene expression through epigenetic mechanisms, interacting with chromatin structure and histone proteins. In aged human lymphocytes, KEDP has been observed to cause pericentromeric chromatin decondensation, potentially reactivating suppressed genes. Preclinical rat models of prostatitis showed that IM administration of KEDP reduced inflammatory markers and helped prevent fibrotic changes in prostate tissue.
Potential Benefits & Side Effects
Observations from preclinical literature (no published human trials).
- In rat prostatitis models, IM KEDP administration reduced inflammation and supported tissue normalization over treatment periods of 15–60 days.
- Studies in benign prostatic hyperplasia (BPH) models showed favorable effects on prostate weight and histological parameters.
- Short bioregulatory peptides of this class generally show favorable tolerability profiles in preclinical work.
- Potential for mild injection‑site reactions (redness, tenderness) as with any IM administration; rotate sites to minimize.
- Note: Human clinical trial data are not yet published; dosing is extrapolated from animal models.
Lifestyle Factors
Complementary strategies for prostate health.
- Maintain a balanced diet rich in vegetables, healthy fats, and adequate protein.
- Regular physical activity supports circulation and overall metabolic health.
- Adequate hydration and limiting alcohol/caffeine may support urinary function.
- Prioritize sleep and stress management to support immune and hormonal balance.
Injection Technique
Intramuscular administration guidance from clinical best‑practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry completely.
- For IM injection, use a 22–25 gauge, 1–1.5 inch needle inserted at 90° into a large muscle (deltoid, vastus lateralis, or gluteus).
- Aspiration before IM injection is no longer routinely recommended for most sites.
- Inject slowly and steadily; wait briefly before withdrawing.
- Rotate sites systematically to avoid muscle irritation or fibrosis.
- Alternative (SC): If subcutaneous route is preferred, use a 23–25 gauge, 5/8 inch needle at 45° into fatty tissue.
important-note
This content is for educational purposes only and is not medical advice. No human clinical trials have been published for Prostamax; all dosing is extrapolated from preclinical research.
Prostamax dosage FAQs
How much bacteriostatic water do you use to reconstitute Prostamax?
Add 2.0 mL bacteriostatic water → 10 mg/mL concentration. for a 20 mg Vial vial. Add the water slowly against the inside wall of the vial and swirl — never shake — until the powder fully dissolves.
What does the Prostamax route: look like?
Weeks 1–2 — 500 mcg (0.5 mg) — 5 units (0.05 mL); Weeks 3–4 — 750 mcg (0.75 mg) — 7.5 units (0.075 mL); Weeks 5–8 — 1,000 mcg (1 mg) — 10 units (0.10 mL); Weeks 9–12 (optional extension) — 1,000 mcg (1 mg) — 10 units (0.10 mL). The full table above lists every step with matching syringe units.
What are the mixing steps for Prostamax?
Draw 2.0 mL bacteriostatic water with a sterile syringe. Inject slowly down the vial wall; avoid foaming. Gently swirl/roll until dissolved (do not shake).
How should reconstituted Prostamax be stored?
Storage: Lyophilized: refrigerate at 4 °C (39.2 °F) short‑term or freeze at −20 °C (−4 °F) long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2 weeks..
How many insulin syringe units equal a Prostamax dose?
Units depend on the water volume you used. Divide your target dose by the vial concentration to get millilitres, then multiply by 100 — 1 unit on a U-100 insulin syringe is 0.01 mL. The Spartan Peptides reconstitution calculator does this conversion for you.
Is Prostamax approved for human use?
No. Prostamax is sold and referenced strictly as a research chemical. Nothing on this page is medical advice and the material is not for human consumption.
Educational and research information only. Not medical advice, not for human consumption. Values are reference figures — always verify your own math with the reconstitution calculator.
On any insulin syringe, 1 unit = 0.01 mL, so unit counts above hold across brands.